Mack Gene

CEO, President

DirectorOfficer

Latest Insider Transactions

1 transactions (past 365 days)

GANX
CEO
Award
$372K
200,000 shares @ $1.86
Filed 2026-03-27Trade 2026-03-24
Gain Therapeutics, Inc.

Mack Gene is a corporate insider with SEC Form 4 filings on record. No transactions have been reported in the past 12 months. Historical filings, if any, are searchable below.